Write in a clean editor, then format for Clinical Trials and Regulatory Science in Cardiology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Clinical Trials and Regulatory Science in Cardiology is a peer-reviewed journal published by Elsevier, covering Coronary Interventions and Diagnostics, Acute Myocardial Infarction Research, Blood Pressure and Hypertension Studies.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Clinical Trials and Regulatory Science in Cardiology 12 (2023) 45–58.
Formats any DOI in Clinical Trials and Regulatory Science in Cardiology style. No sign-up. |
| Publishes research in | Coronary Interventions and Diagnostics Acute Myocardial Infarction Research Blood Pressure and Hypertension Studies Heart Failure Treatment and Management Atrial Fibrillation Management and Outcomes |
| ISSN | 2405-5875 |
| h-index | 9 |
| i10-index | 9 |
| Total citations | 287 |
| Top institutions publishing here | Kumamoto University |
| Journal website | www.sciencedirect.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Purpose: To compare the effect of high intensity interval training (HIIT) and moderate intensity continuous training (MICT) on physical fitness and quality of life (QoL) in patients with chronic heart failure (CHF).\nMethods: Twenty-two male CHF patients (LVEF < 45%, mean age 53.8 ± 8 yr) were studied before and after 12 weeks of supervised aerobic…
Low adherence to cardiovascular medications is often difficult to monitor and is associated with adverse outcomes. We investigated whether there is a difference between the estimated adherence (EA) of the two-dosed regimens of apixaban (A) and the one-dosed regimen of rivaroxaban (R) for stroke prophylaxis in patients with non-valvular atrial fibrillation (AF). This is a…
Coronary artery disease is a devastating disease precisely because an otherwise healthy person in the prime of life may die or become disabled without warning. When the afflicted individual is under the age of 35, the tragic consequences for family, friends, and occupation are particularly catastrophic and unexpected. The purpose of the present study was…
BACKGROUND: We analyzed the literature to assess the coincidental impact on migraines of transcatheter patent foramen ovale (PFO) closure performed for secondary stroke prevention. METHODS: We searched Medline, EMBASE, and the Cochrane database for studies published up until August 2013. We included English-language studies that provided information on complete resolution or improvement in migraine headaches…
Cardiovascular disease (CVD) is now the most prevalent and debilitating disease affecting the Chinese population, we aim to provide the latest nationwide estimates on the prevalence of main CVD risk factors. Using a complex, multistage, probability sampling design, a cross-sectional study was performed in a nationally representative sample of 17,708 adults aged 45 years and…
